1Squier CA,KremerMJ.Biology of oralmucosa and esophagus.J Natl Cancer InstMonogr,2001,29:7～15.
2Xu F,ZhongW,Li J,et al.Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.Anti-cancer Res,2005,25(4):2 943～2 950.
3Poulsen CB,Borup R,Nielsen FC,et al.Microarray-based classification of diffuse large B-cell lymphoma.Eur J Haematol,2005,74(6):453～465.
4Miller CT,Lin L,CasperAM,et al.Genomic amp lification of MET pathways in esophageal adenocarcinoma.Oncogene,2006,25(3):409～418.
5Iravani S,Zhang HQ,Yuan ZQ,et al.Modification of insulin-like growth factor 1 receptor,c-Src,and Bcl2XL protein expression during the p rogression of Barrettps neop lasia.Hum Pathol,2003,34(10):975～982.
6Sunpaweravong P,Sunpaweravong S,Puttawibul P,et al.Epidermal growth factor receptor and cyclin D1 are independently amplified and overexp ressed in esophageal squamous cell carcinoma.J Cancer Res Clin Oncol,2005,131(2):111～119.
7Ziegler S,Rohrs S,Tickenbrock L,et al.Novel target genes of the Wnt pathway and statistical insights intoWnt target promoter regulation.FEBS J,2005,272(7):1 600～1 615.
8Sturm I,Petrowsky H,Volz R,et al.Analysis of P53 /BAX /p16(ink4a/CDKN2) in esophageal squamous cell carcinoma:high BAX and p16(ink4a /CDKN2) identifies patients with good prognosis1 J Clin Oncol,2001,19(8):2 272～2 281.
